Advertisement

Epidemiology of Mesothelioma

  • Dario Mirabelli
  • Alessandro Marinaccio
  • Pietro Comba
  • Corrado MagnaniEmail author
Chapter

Abstract

The chapter presents a summary of evidence regarding the aetiology of malignant mesothelioma (MM), a malignant neoplasm associated to asbestos exposure in the large majority of cases. MM is nowadays the most important cause of death associated to asbestos exposure in the world, and its frequency has been increasing steadily, with over 38,000 deaths estimated each year. Forecasts of future epidemic indicate a reduction expected in the next years in the countries that reduced or banned asbestos use. However, epidemic is expected to continue in the large part of the world where asbestos is still in use. MM registration systems are active only in few countries (Italy, Australia, France and South Korea), while most countries rely on mortality data. Scientific data indicate the association of MM with asbestos exposure, with risk increasing with dose and time since first exposure, both from occupational and nonoccupational origins. Environmental exposure to asbestos-like mineral fibres is the explanation for important MM outbreaks observed in different countries. Other aetiological factors for MM are limited to ionizing radiations that explain only a minimal proportion of cases. The summary of evidence indicates the need for the worldwide extension of the asbestos ban.

Keywords

Malignant mesothelioma Asbestos Pleural cancer Peritoneal cancer Occupation Environmental exposure Cumulative dose Time trends Ionizing radiation SV40 Systematic review 

Notes

Conflict of Interest

DM and CM acted as expert witnesses for the public prosecutor in court trials on asbestos-related diseases.

References

  1. 1.
    Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–71.PubMedPubMedCentralGoogle Scholar
  2. 2.
    IARC. Asbestos. In: IARC monographs evaluation of carcinogenic risks to humans, vol. 14. Lyon: International Agency for Research on Cancer; 1977. p. 1–104.Google Scholar
  3. 3.
    IARC. Asbestos. In: Some inorganic and organometallic compounds. IARC monographs evaluation of carcinogenic risks to humans, vol. 2. Lyon: International Agency for Research on Cancer; 1973. p. 17–47.Google Scholar
  4. 4.
    Newhouse ML, Berry G. Predictions of mortality from mesothelial tumours in asbestos factory workers. Br J Ind Med. 1976;33:147–51.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Peto J, Seidman H, Selikoff IJ. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer. 1982;45:124–35.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Selikoff IJ. Lung cancer and mesothelioma during prospective surveillance of 1249 asbestos insulation workers, 1963-1974. Ann N Y Acad Sci. 1976;271:448–56.PubMedCrossRefGoogle Scholar
  7. 7.
    McDonald JC, McDonald AD, Gibbs GW, Siemiatycki J, Rossiter CE. Mortality in the chrysotile asbestos mines and mills of Quebec. Arch Environ Health. 1971;22:677.PubMedCrossRefGoogle Scholar
  8. 8.
    Finkelstein MM. Mortality among employees of an Ontario asbestos-cement factory. Am Rev Resp Dis. 1984;129:754–61.PubMedCrossRefGoogle Scholar
  9. 9.
    Rubino GF, Piolatto G, Newhouse ML, Scansetti G, Aresini GA, Murray R. Mortality of chrysotile asbestos workers at the Balangero Mine, Northern Italy. Br J Ind Med. 1979;36:187–94.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Davis JM. Mineral fibre carcinogenesis: experimental data relating to the importance of fibre type, size, deposition, dissolution and migration. IARC Sci Publ. 1989;90:33–45.Google Scholar
  11. 11.
    Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44:565–601.CrossRefGoogle Scholar
  12. 12.
    IARC. Asbestos. In: Arsenic, metals, fibres and dusts. IARC monographs evaluation of carcinogenic risks to humans, vol. 100C. Lyon: International Agency for Research on Cancer; 2012. p. 219–310.Google Scholar
  13. 13.
    Landrigan PJ. The third wave of asbestos disease: exposure to asbestos in place. Public health control. Introduction. Ann N Y Acad Sci. 1991;643:xv–xvi.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Anderson HA, Lilis R, Daum SM, Fischbein AS, Selikoff IJ. Household-contact asbestos neoplastic risk. Ann N Y Acad Sci. 1976;271:311–23.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Ferrante D, Bertolotti M, Todesco A, Mirabelli D, Terracini B, Magnani C. Cancer mortality and incidence of mesothelioma in a cohort of wives of asbestos workers in Casale Monferrato, Italy. Environ Health Perspect. 2007;115:1401–5.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Ferrante D, Mirabelli D, Tunesi S, Terracini B, Magnani C. Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment. Occup Environ Med. 2016;73:147–53.CrossRefGoogle Scholar
  17. 17.
    Gardner MJ, Saracci R. Effects on health of non-occupational exposure to airborne mineral fibres. In: Bignon J, Peto J, Saracci R, editors. Non-occupational exposure to mineral fibres, IARC scientific publications no. 90. Lyon: International Agency for Research on Cancer; 1989. p. 375–97.Google Scholar
  18. 18.
    Goldberg P, Goldberg M, Marne MJ, Hirsch A, Tredaniel J. Incidence of pleural mesothelioma in New Caledonia: a 10-year survey (1978-1987). Arch Environ Health. 1991;46:306–9.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Kurumatani N, Kumagai S. Mapping the risk of mesothelioma due to neighborhood asbestos exposure. Am J Respir Crit Care Med. 2008;178:624–9.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Magnani C, Agudo A, González CA, Andrion A, Calleja A, Chellini E, Dalmasso P, Escolar A, Hernandez S, Ivaldi C, Mirabelli D, Ramirez J, Turuguet D, Usel M, Terracini B. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer. 2000;83:104–11.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    HEI Health Effects Institute - Asbestos Research. Asbestos in public and commercial buildings. Cambridge: Health Effects Institute - Asbestos Research; 1991.Google Scholar
  22. 22.
    Magnani C, Bianchi C, Chellini E, Consonni D, Fubini B, Gennaro V, Marinaccio A, Menegozzo M, Mirabelli D, Merler E, Merletti F, Musti M, Oddone E, Romanelli A, Terracini B, Zona A, Zocchetti C, Alessi M, Baldassarre A, Dianzani I, Maule M, Mensi C, Silvestri S. III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues. Med Lav. 2015;106:325–32.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Novello S, Pinto C, Torri V, Porcu L, Di Maio M, Tiseo M, Ceresoli G, Magnani C, Silvestri S, Veltri A, Papotti M, Rossi G, Ricardi U, Trodella L, Rea F, Facciolo F, Granieri A, Zagonel V, Scagliotti G. The third italian consensus conference for malignant pleural mesothelioma: state of the art and recommendations. Crit Rev Oncol Hematol. 2016;104:9–20.CrossRefGoogle Scholar
  24. 24.
    Pinto C, Novello S, Torri V, Ardizzoni A, Betta PG, Bertazzi PA, Casalini GA, Fava C, Fubini B, Magnani C, Mirabelli D, Papotti M, Ricardi U, Rocco G, Pastorino U, Tassi G, Trodella L, Zompatori M, Scagliotti G. Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations. Cancer Treat Rev. 2013;39:328–39.CrossRefGoogle Scholar
  25. 25.
    Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41:5–15.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Odgerel CO, Takahashi K, Sorahan T, Driscoll T, Fitzmaurice C, Yoko-O M, Sawanyawisuth K, Furuya S, Tanaka F, Horie S, Zandwijk NV, Takala J. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med. 2017;74:851–8.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011;89:716–24.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Park EK, Takahashi K, Hoshuyama T, Cheng TJ, Delgermaa V, Le GV, Sorahan T. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011;119:514–8.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Diandini R, Takahashi K, Park EK, Jiang Y, Movahed M, Le GV, Lee LJ, Delgermaa V, Kim R. Potential years of life lost (PYLL) caused by asbestos-related diseases in the world. Am J Ind Med. 2013;56:993–1000.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Marinaccio A, Binazzi A, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Riboldi L, Merler E, Zotti RD, Romanelli A, Chellini E, Silvestri S, Pascucci C, Romeo E, Menegozzo S, Musti M, Cavone D, Cauzillo G, Tumino R, Nicita C, Melis M, Iavicoli S. Pleural malignant mesothelioma epidemic. Incidence, modalities of asbestos exposure and occupations involved from the Italian national register. Int J Cancer. 2012;130:2146–54.PubMedCrossRefGoogle Scholar
  31. 31.
    Marinaccio A, Binazzi A, Bonafede M, et al. Quinto rapporto. Il Registro Nazionale dei Mesoteliomi. INAIL, Milano. 2015.Google Scholar
  32. 32.
    Ferrante P, Binazzi A, Branchi C, Marinaccio A. National epidemiological surveillance systems of mesothelioma cases. Epidemiol Prev. 2016;40:215–23.Google Scholar
  33. 33.
    Leigh J, Davidson P, Hendrie L, Berry D. Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med. 2002;41:188–201.PubMedCrossRefGoogle Scholar
  34. 34.
    Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Savès M, de Quillacq A, Frenay C, Chamming’s S, Arveux P, Boutin C, Launoy G, Pairon JC, Astoul P, Galateau-Sallé F, Brochard P. The French national mesothelioma surveillance program. Occup Environ Med. 2006;63:390–5.Google Scholar
  35. 35.
    Jung SH, Kim HR, Koh SB, Yong SJ, Chung MJ, Lee CH, Han J, Eom MS, Oh SS. A decade of malignant mesothelioma surveillance in Korea. Am J Ind Med. 2012;55:869–75.PubMedCrossRefGoogle Scholar
  36. 36.
    Marinaccio A, Montanaro F, Mastrantonio M, et al. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer. 2005;115:142–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Magnani C, Dalmasso P, Biggeri A, Ivaldi C, Mirabelli D, Terracini B. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect. 2001;109:915–9.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Musti M, Pollice A, Cavone D, Dragonieri S, Bilancia M. The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case-control study in the city of Bari (Italy). Int Arch Occup Environ Health. 2009;82:489–97.PubMedCrossRefGoogle Scholar
  39. 39.
    Mensi C, Riboldi L, De Matteis S, Bertazzi PA, Consonni D. Impact of an asbestos cement factory on mesothelioma incidence: global assessment of effects of occupational, familial, and environmental exposure. Environ Int. 2015;74:191–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Dodoli D, Del Nevo M, Fiumalbi C, Iaia TE, Cristaudo A, Comba P, Viti C, Battista G. Environmental household exposures to asbestos and occurrence of pleural mesothelioma. Am J Ind Med. 1992;21:681–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Comba P, D’Angelo M, Fazzo L, Magnani C, Marinaccio A, Mirabelli D, Terracini B. Mesothelioma in Italy: the Casale Monferrato model to a national epidemiological surveillance system. Ann Ist Super Sanita. 2018;54:139–48.PubMedGoogle Scholar
  42. 42.
    Mirabelli D, Calisti R, Barone-Adesi F, Fornero E, Merletti F, Magnani C. Excess of mesotheliomas after exposure to chrysotile in Balangero, Italy. Occup Environ Med. 2008;65:815–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Marinaccio A, Binazzi A, Bonafede M, Corfiati M, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Merler E, Negro C, Romanelli A, Chellini E, Silvestri S, Cocchioni M, Pascucci C, Stracci F, Ascoli V, Trafficante L, Angelillo I, Musti M, Cavone D, Cauzillo G, Tallarigo F, Tumino R, Melis M. Malignant mesothelioma due to non-occupational asbestos exposure from Italian national surveillance system (ReNaM): epidemiology and public health issues. Occup Environ Med. 2015;72:648–55.PubMedCrossRefGoogle Scholar
  44. 44.
    Corfiati M, Scarselli A, Binazzi A, et al. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry. BMC Cancer. 2015;15:286.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Binazzi A, Marinaccio A, Corfiati M, Bruno C, Fazzo L, Pasetto R, Pirastu R, Biggeri A, Catelan D, Comba P, Zona A. Mesothelioma incidence and asbestos exposure in Italian national priority contaminated sites. Scand J Work Environ Health. 2017;43:550–9.PubMedGoogle Scholar
  46. 46.
    Okello C, Treasure T, Nicholson AG, Peto J, Møller H. Certified causes of death in patients with mesothelioma in South East England. BMC Cancer. 2009;9:28.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
  48. 48.
    Mazurek JM, Syamlal G, Wood JM, Hendricks SA, Weston A. Malignant mesothelioma mortality - United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2017;66:214–8.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Gogou E, Kerenidi T, Chamos V, Zintzaras E, Gourgoulianis KI. Mesothelioma mortality in Greece from 1983 to 2003. Int J Clin Pract. 2009;63:944–8.PubMedCrossRefGoogle Scholar
  50. 50.
    López-Abente G, Hernández-Barrera V, Pollán M, Aragonés N, Pérez-Gómez B. Municipal pleural cancer mortality in Spain. Occup Environ Med. 2005;62:195–9.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    López-Abente G, García-Gómez M, Menéndez-Navarro A, Fernández-Navarro P, Ramis R, García-Pérez J, Cervantes M, Ferreras E, Jiménez-Muñoz M, Pastor-Barriuso R. Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020. BMC Cancer. 2013;13:528.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Pedra F, Tambellini AT, Pereira Bde B, da Costa AC, de Castro HA. Mesothelioma mortality in Brazil, 1980-2003. Int J Occup Environ Health. 2008;14(3):170–5. Erratum in: Int J Occup Environ Health. 2009;15:391PubMedCrossRefGoogle Scholar
  53. 53.
    Pasetto R, Terracini B, Marsili D, Comba P. Occupational burden of asbestos-related cancer in Argentina, Brazil, Colombia, and Mexico. Ann Glob Health. 2014;80:263–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Fazzo L, Minelli G, De Santis M, Bruno C, Zona A, Conti S, Comba P. Epidemiological surveillance of mesothelioma mortality in Italy. Cancer Epidemiol. 2018;55:184–91.PubMedCrossRefGoogle Scholar
  55. 55.
    Ferrante P, Mastrantonio M, Uccelli R, Corfiati M, Marinaccio A. Pleural mesothelioma mortality in Italy: time series reconstruction (1970-2009) and comparison with incidence (2003-2008). Epidemiol Prev. 2016;40:205–14.PubMedGoogle Scholar
  56. 56.
    Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, Strnad M, Jechov’a M, Storm HH, Aareleid T, Hakulinen T, Velten M, Lef’evre H, Danzon A, Buemi A, Daur’es JP, Ménégoz F, Raverdy N, Sauvage M, Ziegler H, Comber H, Paci E, Vercelli M, De Lisi V, Tumino R, Zanetti R, Berrino F, Stanta G, Langmark F, Rachtan J, Mezyk R, Blaszczyk J, Ivan P, Primic-Zakelj M, Martínez AC, Izarzugaza I, Borràs J, Garcia CM, Garau I, Sánchez NC, Aicua A, Barlow L, Torhorst J, Bouchardy C, Levi F, Fisch T, Probst N, Visser O, Quinn M, Gavin A, Brewster D, Mikov M, ENCR Working Group. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control. 2003;14:791–803.PubMedCrossRefGoogle Scholar
  57. 57.
    Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E. The mesothelioma epidemic in Western Europe: an update. Br J Cancer. 2004;90:1022–4.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Hodgson JT, McElvenny DM, Darnton AJ, et al. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005;92:587–93.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Tan E, Warren N, Darnton AJ, Hodgson JT. Projection of mesothelioma mortality in Britain using Bayesian methods. Br J Cancer. 2010;103:430–6.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Le Stang N, Belot A, Gilg Soit Ilg A, et al. Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005. Int J Cancer. 2010;126:232–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, Bonafede M, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Mazzoleni G, Merler E, Girardi P, Negro C, D’Agostin F, Romanelli A, Chellini E, Silvestri S, Pascucci C, Calisti R, Stracci F, Romeo E, Ascoli V, Trafficante L, Carrozza F, Angelillo IF, Cavone D, Cauzillo G, Tallarigo F, Tumino R, Melis M, Iavicoli S, ReNaM Working Group. The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure. Occup Environ Med. 2018;75:254–62.PubMedCrossRefGoogle Scholar
  62. 62.
    Segura O, Burdorf A, Looman C. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med. 2003;60:50–5.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Kjaergaard J, Andersson M. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health. 2000;26:112–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Ulvestad B, Kjaerheim K, Møller B, Andersen A. Incidence trends of mesothelioma in Norway, 1965-1999. Int J Cancer. 2003;107:94–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009;39:576–88.PubMedCrossRefGoogle Scholar
  66. 66.
    Myojin T, Azuma K, Okumura J, Uchiyama I. Future trends of mesothelioma mortality in Japan based on a risk function. Ind Health. 2012;50:197–204.PubMedCrossRefGoogle Scholar
  67. 67.
    Le GV, Takahashi K, Park EK, et al. Asbestos use and asbestos-related diseases in Asia: past, present and future. Respirology. 2001;16:767–75.CrossRefGoogle Scholar
  68. 68.
    Järvholm B, Burdorf A. Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden. Scand J Public Health. 2015;43:875–81.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Buresti G, Colonna F, Corfiati M, et al. Economic impact of malignant mesothelioma in Italy: an estimate of the public and social costs. Med Lav. 2017;108:358–66.PubMedGoogle Scholar
  70. 70.
    Burlikov T, Michailova L. Asbestos content of the soil and endemic pleural asbestosis. Environ Res. 1970;3:443–51.CrossRefGoogle Scholar
  71. 71.
    Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56:505–13.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Yazicioglu S, Ilçayto R, Balci K, Sayli BS, Yorulmaz B. Pleural calcification, pleural mesotheliomas, and bronchial cancers caused by tremolite dust. Thorax. 1980;35:564–9.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Pasetto R, Comba P, Marconi A. Mesothelioma associated with environmental exposures. Med Lav. 2005;96:330–7.PubMedGoogle Scholar
  74. 74.
    Liu XZ, Luo SQ, Wang ZM, Wang MZ, Zhan CL. An investigation of crocidolite contamination and mesothelioma in a rural area of China. Biomed Environ Sci. 1990;3:156–65.PubMedGoogle Scholar
  75. 75.
    Luo S, Liu X, Mu S, Tsai SP, Wen CP. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. Occup Environ Med. 2003;60:35–41.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med. 2005;172:1019–25.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Baris YI, Sahin AA, Ozesmi M, Kerse I, Ozen E, Kolacan B, Altinörs M, Göktepeli A. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia. Thorax. 1978;33:181–92.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Bariş YI, Grandjean P. Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. J Natl Cancer Inst. 2006;98:414–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Simonato L, Bariş R, Saracci R, et al. Relation of environmental exposure to erionite fibres to risk of respiratory cancer. IARC Sci Publ. 1989;90:398–405.Google Scholar
  80. 80.
    IARC. Erionite. In: Arsenic, metals, fibres and dusts. IARC monographs evaluation of carcinogenic risks to humans, vol. 100C. Lyon: International Agency for Research on Cancer; 2012. p. 311–6.Google Scholar
  81. 81.
    IARC. Silica and some silicates. IARC monographs evaluation of carcinogenic risks to humans, vol. 42. International Agency for Research on Cancer: Lyon; 1987.Google Scholar
  82. 82.
    Espejo-Herrera N, Gràcia-Lavedan E, Boldo E, Aragonés N, Pérez-Gómez B, Pollán M, Molina AJ, Fernández T, Martín V, La Vecchia C, Bosetti C, Tavani A, Polesel J, Serraino D, Gómez Acebo I, Altzibar JM, Ardanaz E, Burgui R, Pisa F, Fernández-Tardón G, Tardón A, Peiró R, Navarro C, Castaño-Vinyals G, Moreno V, Righi E, Aggazzotti G, Basagaña X, Nieuwenhuijsen M, Kogevinas M, Villanueva CM. Colorectal cancer risk and nitrate exposure through drinking water and diet. Int J Cancer. 2016;139:334–46.PubMedCrossRefGoogle Scholar
  83. 83.
    Baumann F, Maurizot P, Mangeas M, Ambrosi JP, Douwes J, Robineau B. Pleural mesothelioma in New Caledonia: associations with environmental risk factors. Environ Health Perspect. 2011;119:695–700.PubMedCrossRefGoogle Scholar
  84. 84.
    Baumann F, Rougier Y, Ambrosi JP, Robineau BP. Pleural mesothelioma in New Caledonia: an acute environmental concern. Cancer Detect Prev. 2007;31:70–6.PubMedCrossRefGoogle Scholar
  85. 85.
    Naik SL, Lewin M, Young R, Dearwent SM, Lee R. Mortality from asbestos-associated disease in Libby, Montana 1979-2011. J Expo Sci Environ Epidemiol. 2017;27:207–13.PubMedCrossRefGoogle Scholar
  86. 86.
    Whitehouse AC, Black CB, Heppe MS, Ruckdeschel J, Levin SM. Environmental exposure to Libby asbestos and mesotheliomas. Am J Ind Med. 2008;51:877–80.PubMedCrossRefGoogle Scholar
  87. 87.
    Caputo A, De Santis M, Manno V, Cauzillo G, Bruni BM, Palumbo L, Conti S, Comba P. Health impact of asbestos fibres naturally occurring in Mount Pollino area (Basilicata Region, Southern Italy). Epidemiol Prev. 2018;42:142–50.PubMedGoogle Scholar
  88. 88.
    Bruno C, Tumino R, Fazzo L, Cascone G, Cernigliaro A, De Santis M, Giurdanella MC, Nicita C, Rollo PC, Scondotto S, Spata E, Zona A, Comba P. Incidence of pleural mesothelioma in a community exposed to fibres with fluoro-edenitic composition in Biancavilla (Sicily, Italy). Ann Ist Super Sanita. 2014;50:111–8.PubMedGoogle Scholar
  89. 89.
    Paoletti L, Batisti D, Bruno C, Di Paola M, Gianfagna A, Mastrantonio M, Nesti M, Comba P. Unusually high incidence of malignant pleural mesothelioma in a town of the eastern Sicily: an epidemiological and environmental study. Arch Environ Occup Health. 2000;55:392–8.CrossRefGoogle Scholar
  90. 90.
    Comba P, Gianfagna A, Paoletti L. The pleural mesothelioma cases in Biancavilla are related to the new fluoro-edenite fibrous amphibole. Arch Environ Occup Health. 2003;58:229–32.CrossRefGoogle Scholar
  91. 91.
    Gianfagna A, Oberti R. Fluoro-edenite from Biancavilla (Catania, Sicily, Italy). Crystal chemistry of a new amphibole end-member. Am Mineral. 2001;83:1486–93.Google Scholar
  92. 92.
    Belpoggi F, Tibaldi E, Lauriola M, Bua L, Falcioni L, Chiozzotto D, Manservisi F, Manservigi M, Soffritti M. The efficacy of long-term bioassays in predicting human risks: mesotheliomas induced by fluoro-edenitic fibres present in lava stone from the Etna volcano in Biancavilla, Italy. Eur J Oncol. 2011;16:185–96.Google Scholar
  93. 93.
    Soffritti M, Minardi F, Bua L, Degli Esposti D, Belpoggi F. First experimental evidence of peritoneal and pleural mesotheliomas induced by fluoro-edenite fibres present in Etnean volcanic material from Biancavilla (Sicily, Italy). Eur J Oncol. 2004;9:169–75.Google Scholar
  94. 94.
    IARC. Fluoro-edenite. In: Some nanomaterials and some fibres. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 111. Lyon: International Agency for Research on Cancer; 2017. p. 215–42.Google Scholar
  95. 95.
    IARC. Man-made vitreous fibres. IARC monographs evaluation of carcinogenic risks to humans, vol. 81. International Agency for Research on Cancer: Lyon; 2002.Google Scholar
  96. 96.
    Utell MJ, Maxim LD. Refractory ceramic fiber (RCF) toxicity and epidemiology: a review. Inhal Toxicol. 2010;22:500–21.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    IARC. Carbon nanotubes. In: Some nanomaterials and some fibres. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 111. Lyon: International Agency for Research on Cancer; 2017. p. 35–214.Google Scholar
  98. 98.
    Magnani C, Fubini B, Mirabelli D, Bertazzi PA, Bianchi C, Chellini E, Gennaro V, Marinaccio A, Menegozzo M, Merler E, Merletti F, Musti M, Pira E, Romanelli A, Terracini B, Zona A. Pleural mesothelioma: epidemiological and public health issues. Report from the Second Italian Consensus Conference on Pleural Mesothelioma. Med Lav. 2013;104:191–202.PubMedPubMedCentralGoogle Scholar
  99. 99.
    Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(Suppl 1):1–47.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Boffetta P, Stayner LT. Pleural and peritoneal neoplasms. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 659–73.CrossRefGoogle Scholar
  101. 101.
    Goodman M, Morgan RW, Ray R, Malloy CD, Zhao K. Cancer in asbestos-exposed occupational cohorts: a meta-analysis. Cancer Causes Control. 1999;10:453–65.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Lash TL, Crouch EA, Green LC. A meta-analysis of the relation between cumulative exposure to asbestos and relative risk of lung cancer. Occup Environ Med. 1997;54:254–63.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Albin M, Jakobsson K, Attewell R, et al. Mortality and cancer morbidity in cohorts of asbestos cement workers and referents. Br J Ind Med. 1990;47:602–10.PubMedPubMedCentralGoogle Scholar
  104. 104.
    Berry G, de Klerk NH, Reid A, et al. Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Occup Environ Med. 2004;61:e14.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Berry G, Newhouse ML, Wagner JC. Mortality from all cancers of asbestos factory workers in East London 1933-80. Occup Environ Med. 2000;57:782–5.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Berry G, Reid A, Aboagye-Sarfo P, de Klerk NH, Olsen NJ, Merler E, Franklin P, Musk AW. Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up. Br J Cancer. 2012;106:1016–20.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Berry G. Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoon asbestos workers. Br J Ind Med. 1991;48:793–802.PubMedPubMedCentralGoogle Scholar
  108. 108.
    Carel R, Boffetta P, Kauppinen T, Teschke K, Andersen A, Jäppinen P, Pearce N, Rix BA, Bergeret A, Coggon D, Persson B, Szadkowska-Stanczyk I, Kielkowski D, Henneberger P, Kishi R, Facchini LA, Sala M, Colin D, Kogevinas M. Exposure to asbestos and lung and pleural cancer mortality among pulp and paper industry workers. J Occup Environ Med. 2002;44:579–84.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Clin B, Morlais F, Launoy G, Guizard AV, Dubois B, Bouvier V, Desoubeaux N, Marquignon MF, Raffaelli C, Paris C, Galateau-Salle F, Guittet L, Letourneux M. Cancer incidence within a cohort occupationally exposed to asbestos: a study of dose—response relationships. Occup Environ Med. 2011;68:832–6.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    de Klerk NH, Armstrong BK, Musk AW, Hobbs MS. Cancer mortality in relation to measures of occupational exposure to crocidolite at Wittenoom Gorge in Western Australia. Br J Ind Med. 1989;46:529–36.PubMedPubMedCentralGoogle Scholar
  111. 111.
    Enterline PE, Hartley J, Henderson V. Asbestos and cancer: a cohort followed up to death. Br J Ind Med. 1987;44:396–401.PubMedPubMedCentralGoogle Scholar
  112. 112.
    Finkelstein MM, Meisenkothen C. Malignant mesothelioma among employees of a Connecticut factory that manufactured friction materials using chrysotile asbestos. Ann Occup Hyg. 2010;54:692–6.PubMedGoogle Scholar
  113. 113.
    Finkelstein MM. Analysis of the exposure-response relationship for mesothelioma among asbestos-cement factory workers. Ann N Y Acad Sci. 1991;643:85–9.PubMedCrossRefGoogle Scholar
  114. 114.
    Hansen J, de Klerk NH, Musk AW, Hobbs MS. Environmental exposure to crocidolite and mesothelioma: exposure-response relationships. Am J Respir Crit Care Med. 1998;157:69–75.PubMedCrossRefGoogle Scholar
  115. 115.
    Iwatsubo Y, Pairon JC, Boutin C, Ménard O, Massin N, Caillaud D, Orlowski E, Galateau-Salle F, Bignon J, Brochard P. Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study. Am J Epidemiol. 1998;148:133–42.PubMedCrossRefGoogle Scholar
  116. 116.
    Jiang Z, Chen T, Chen J, Ying S, Gao Z, He X, Miao C, Yu M, Feng L, Xia H, Wu W, Chen R, Morinaga K, Lou J, Zhang X. Hand-spinning chrysotile exposure and risk of malignant mesothelioma: a case-control study in Southeastern China. Int J Cancer. 2018;142:514–23.PubMedCrossRefGoogle Scholar
  117. 117.
    Koskinen K, Pukkala E, Martikainen R, Reijula R, Karjalainen A. Different measures of asbestos exposure in estimating risk of lung cancer and mesothelioma among construction workers. J Occup Environ Med. 2002;44:1190–6.PubMedCrossRefGoogle Scholar
  118. 118.
    Kumagai S, Kurumatani N. Asbestos fiber concentration in the area surrounding a former asbestos cement plant and excess mesothelioma deaths in residents. Am J Ind Med. 2009;52:790–8.PubMedCrossRefGoogle Scholar
  119. 119.
    Lacourt A, Gramond C, Rolland P, Ducamp S, Audignon S, Astoul P, Chamming’s S, Gilg Soit Ilg A, Rinaldo M, Raherison C, Galateau-Salle F, Imbernon E, Pairon JC, Goldberg M, Brochard P. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma. Thorax. 2014;69:532–9.PubMedCrossRefGoogle Scholar
  120. 120.
    Lacourt A, Leffondré K, Gramond C, Ducamp S, Rolland P, Gilg Soit Ilg A, Houot M, Imbernon E, Févotte J, Goldberg M, Brochard P. Temporal patterns of occupational asbestos exposure and risk of pleural mesothelioma. Eur Respir J. 2012;39:1304–12.PubMedCrossRefGoogle Scholar
  121. 121.
    Langer AM. Health experience of some US and Canadian workers exposed to asbestos: foundation for risk assessment. In: Nolan RP, Langer AM, Ross M, Wicks FJ, Martin RF, editors. The health effects of chrysotile, Canadian mineralogist special publication 5. Ottawa: Mineralogical Association of Canada; 2001. p. 9–20.Google Scholar
  122. 122.
    Larson TC, Antao VC, Bove FJ. Vermiculite worker mortality: estimated effects of occupational exposure to Libby amphibole. J Occup Environ Med. 2010;52:555–60.PubMedCrossRefGoogle Scholar
  123. 123.
    Liddell FD, McDonald AD, McDonald JC. The 1891–1920 birth cohort of Quebec chrysotile miners and millers: development from 1904 and mortality to 1992. Ann Occup Hyg. 1997;41:13–36.PubMedCrossRefGoogle Scholar
  124. 124.
    McDonald AD, Fry JS, Woolley AJ, McDonald JC. Dust exposure and mortality in an American chrysotile asbestos friction products plant. Br J Ind Med. 1984;41:151–7.PubMedPubMedCentralGoogle Scholar
  125. 125.
    McDonald JC, Harris J, Armstrong B. Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby, Montana. Occup Environ Med. 2004;61:363–6.PubMedPubMedCentralCrossRefGoogle Scholar
  126. 126.
    McDonald JC, Liddell FD, Dufresne A, McDonald AD. The 1891-1920 birth cohort of Quebec chrysotile miners and millers: mortality 1976-88. Br J Ind Med. 1993;50:1073–81.PubMedPubMedCentralGoogle Scholar
  127. 127.
    Meurman LO, Pukkala E, Hakama M. Incidence of cancer among antophyllite asbestos miners in Finland. Occup Environ Med. 1994;51:421–5.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Mowé G, Gylseth B, Hartveit F, Skaug V. Fiber concentration in lung tissue of patients with malignant mesothelioma: a case-control study. Cancer. 1985;56:1089–93.PubMedCrossRefPubMedCentralGoogle Scholar
  129. 129.
    Musk AW, de Klerk NH, Olsen N, et al. Mortality in miners and millers of crocidolite in Western Australia: follow-up to 1999. Ann Occup Hyg. 2002;46(Suppl 1):90–2.CrossRefGoogle Scholar
  130. 130.
    Musk AW, de Klerk NH, Reid A, et al. Mortality of former crocidolite (blue asbestos) miners and millers at Wittenoom. Occup Environ Med. 2008;65:541–3.PubMedCrossRefGoogle Scholar
  131. 131.
    Newhouse ML, Berry G, Wagner JC. Mortality of factory workers in East London 1933-80. Br J Ind Med. 1985;42:4–11.PubMedPubMedCentralGoogle Scholar
  132. 132.
    Offermans NS, Vermeulen R, Burdorf A, Goldbohm RA, Kauppinen T, Kromhout H, van den Brandt PA. Occupational asbestos exposure and risk of pleural mesothelioma, lung cancer, and laryngeal cancer in the Prospective Netherlands Cohort Study. J Occup Environ Med. 2014;56:6–19.PubMedCrossRefGoogle Scholar
  133. 133.
    Ohlson CG, Klaesson B, Hogstedt C. Mortality among asbestos-exposed workers in a railroad workshop. Scand J Work Environ Health. 1984;10:283–91.PubMedCrossRefGoogle Scholar
  134. 134.
    Peto J. The hygiene standard for chrysotile asbestos. Lancet. 1978;1:484–9.PubMedCrossRefGoogle Scholar
  135. 135.
    Piolatto G, Negri E, La Vecchia C, Pira E, De Carli A, Peto J. An update on cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med. 1990;47:810–4.PubMedPubMedCentralGoogle Scholar
  136. 136.
    Pira E, Pelucchi C, Piolatto PG, et al. Mortality from cancer and other causes in the Balangero cohort of chrysotile asbestos miners. Occup Environ Med. 2009;66:805–9.PubMedCrossRefGoogle Scholar
  137. 137.
    Pira E, Romano C, Donato F, Pelucchi C, Vecchia C, Boffetta P. Mortality from cancer and other causes among Italian chrysotile asbestos miners. Occup Environ Med. 2017;74:558–63.PubMedCrossRefGoogle Scholar
  138. 138.
    Reid A, Berry G, de Klerk N, Hansen J, Heyworth J, Ambrosini G, Fritschi L, Olsen N, Merler E, Musk AW. Age and sex differences in malignant mesothelioma after residential exposure to blue asbestos (crocidolite). Chest. 2007;131:376–82.PubMedCrossRefGoogle Scholar
  139. 139.
    Reid A, Berry G, Heyworth J, et al. Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia. Occup Environ Med. 2009;66:169–74.PubMedCrossRefGoogle Scholar
  140. 140.
    Reid A, Franklin P, Olsen N, Sleith J, Samuel L, Aboagye-Sarfo P, de Klerk N, Musk AW. All-cause mortality and cancer incidence among adults exposed to blue asbestos during childhood. Am J Ind Med. 2013;56:133–45.PubMedCrossRefGoogle Scholar
  141. 141.
    Reid A, Heyworth J, de Klerk N, Musk AW. The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, Western Australia. Occup Environ Med. 2008;65:743–9.PubMedCrossRefGoogle Scholar
  142. 142.
    Reid A, Merler E, Peters S, Jayasinghe N, Bressan V, Franklin P, Brims F, de Klerk NH, Musk AW. Migration and work in postwar Australia: mortality profile comparisons between Australian and Italian workers exposed to blue asbestos at Wittenoom. Occup Environ Med. 2018;75:29–36.PubMedCrossRefGoogle Scholar
  143. 143.
    Rödelsperger K, Jöckel KH, Pohlabeln H, et al. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results from a German hospital based case-control study. Am J Ind Med. 2001;39:262–75.PubMedCrossRefGoogle Scholar
  144. 144.
    Seidman H, Selikoff IJ, Gelb SK. Mortality experience of amosite asbestos factory workers: dose-response relationships 5 to 40 years after onset of short-term work exposure. Am J Ind Med. 1986;10:479–514.PubMedCrossRefGoogle Scholar
  145. 145.
    Seidman H, Selikoff IJ, Hammond EC. Short-term asbestos work exposure and long-term observation. Ann N Y Acad Sci. 1979;330:61–89.PubMedCrossRefGoogle Scholar
  146. 146.
    Świątkowska B, Szeszenia-Dąbrowska N. Mesothelioma continues to increase even 40 years after exposure - evidence from long-term epidemiological observation. Lung Cancer. 2017;108:121–5.PubMedCrossRefGoogle Scholar
  147. 147.
    Albin M, Johanssen L, Pooley FD, et al. Mineral fibres, fibrosis, and asbestos bodies in lung tissue from deceased asbestos cement workers. Br J Ind Med. 1990;47:767–74.PubMedPubMedCentralGoogle Scholar
  148. 148.
    Gilham C, Rake C, Burdett G, Nicholson AG, Davison L, Franchini A, Carpenter J, Hodgson J, Darnton A, Peto J. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occup Environ Med. 2016;73:290–9.PubMedCrossRefGoogle Scholar
  149. 149.
    Howel D, Gibbs A, Arblaster L, et al. Mineral fibre analysis and routes of exposure to asbestos in the development of mesothelioma in an English region. Occup Environ Med. 1999;56:51–8.PubMedPubMedCentralCrossRefGoogle Scholar
  150. 150.
    Johansson LG, Albin MP, Jakobsson KM, Welinder HEC, Ranstam PJ, Attewell RG. Ferruginous bodies and pulmonary fibrosis in dead low to moderately exposed asbestos cement workers: histological examination. Br J Ind Med. 1987;44:550–8.PubMedPubMedCentralGoogle Scholar
  151. 151.
    McDonald JC, Armstrong B, Case B, et al. Mesothelioma and asbestos fiber type. Evidence from lung tissue analyses. Cancer. 1989;63:1544–7.PubMedCrossRefGoogle Scholar
  152. 152.
    McDonald JC, Armstrong BG, Edwards CW, et al. Casereferent survey of young adults with mesothelioma: I. Lung fibre analyses. Ann Occup Hyg. 2001;45:513–8.PubMedCrossRefGoogle Scholar
  153. 153.
    Rödelsperger K, Woitowitz HJ, Brückel B, et al. Dose-response relationship between amphibole fiber lung burden and mesothelioma. Cancer Detect Prev. 1999;23:183–93.PubMedCrossRefGoogle Scholar
  154. 154.
    Rogers AJ, Leigh J, Berry G, et al. Relationship between lung asbestos fiber type and concentration and relative risk of mesothelioma. A case-control study. Cancer. 1991;67:1912–20.PubMedCrossRefPubMedCentralGoogle Scholar
  155. 155.
    Tuomi T, Huuskonen MS, Virtamo M, et al. Relative risk of mesothelioma associated with different levels of exposure to asbestos. Scand J Work Environ Health. 1991;17:404–8.PubMedCrossRefGoogle Scholar
  156. 156.
    Peto J, Doll R, Hermon C, et al. Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg. 1985;29:305–55.PubMedGoogle Scholar
  157. 157.
    Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med. 1992;34:718–21.PubMedGoogle Scholar
  158. 158.
    Marinaccio A, Binazzi A, Cauzillo G, Cavone D, Zotti RD, Ferrante P, Gennaro V, Gorini G, Menegozzo M, Mensi C, Merler E, Mirabelli D, Montanaro F, Musti M, Pannelli F, Romanelli A, Scarselli A, Tumino R, Italian Mesothelioma Register (ReNaM) Working Group. Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer. 2007;43:2722–8.PubMedCrossRefGoogle Scholar
  159. 159.
    Barone Adesi F, Ferrante D, Bertolotti M, et al. Long-term mortality from pleural and peritoneal cancer after exposure to asbestos. Possible role of asbestos clearance. Int J Cancer. 2008;123:912–6.PubMedCrossRefGoogle Scholar
  160. 160.
    Ferrante D, Chellini E, Merler E, Pavone V, Silvestri S, Miligi L, Gorini G, Bressan V, Girardi P, Ancona L, Romeo E, Luberto F, Sala O, Scarnato C, Menegozzo S, Oddone E, Tunesi S, Perticaroli P, Pettinari A, Cuccaro F, Mattioli S, Baldassarre A, Barone-Adesi F, Cena T, Legittimo P, Marinaccio A, Mirabelli D, Musti M, Pirastu R, Ranucci A, Magnani C, The Working Group. Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure. Occup Environ Med. 2017;74:887–98.PubMedCrossRefGoogle Scholar
  161. 161.
    Reid A, de Klerk NH, Magnani C, Ferrante D, Berry G, Musk AW, Merler E. Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis. Thorax. 2014;69:843–50.PubMedCrossRefGoogle Scholar
  162. 162.
    Goodman JE, Nascarella MA, Valberg PA. Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control. 2009;20:1237–54.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Dario Mirabelli
    • 1
  • Alessandro Marinaccio
    • 2
  • Pietro Comba
    • 3
  • Corrado Magnani
    • 4
    Email author
  1. 1.Cancer Epidemiology, CPO PiemonteUniversity of TurinTurinItaly
  2. 2.Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Unit of Occupational and Environmental EpidemiologyINAIL, Italian National Institute for Insurance Against Accidents at WorkRomeItaly
  3. 3.Unit of Environmental and Social Epidemiology, Department of Environment and Health, Istituto Superiore di SanitàRomeItaly
  4. 4.Department of Translational MedicineUniversity of Eastern Piedmont, and Cancer Epidemiology Unit, Maggiore Hospital and CPO PiedmontNovaraItaly

Personalised recommendations